Name of this trial: DAWN-303 What type of cancer is this for? Metastatic pancreatic cancer Who is this trial for? Patients who have not had any treatment for metastatic pancreatic disease. What biomarkers are involved? KRAS G12D What is the National Clinical Trial #? NCT07522073 Brief summary of this trial: Randomized, double-blinded, Ph. 3 trial of chemotherapy with or without INCB161734 in previously
Phone: (800) 411-7999
